文献速递胸部腹部技术与安全CTPET

18F-FDG PET/CT 与 CT 扫描在结直肠癌肝转移术后患者肺转移检测中的作用

Role of 18F-FDG PET/CT vs CT-scan in patients with pulmonary metastases previously operated on for colorectal liver metastases.
PubMed 文献 · Br J Radiol · 2017-10-27

该前瞻性研究纳入57例因结直肠癌肝转移术后随访中CT发现肺转移并接受肺转移灶切除的患者,以组织学为对照,比较CT与18F-FDG PET/CT对101个切除肺结节的检出能力。CT检出结节数更多(89 vs 75,p < 0.001),敏感度更高(90% vs 76%)但特异度更低(50% vs 75%);PET/CT在4例患者中检出更多肺结节、在6例患者中检出更多肺外病变。

要点

  • CT检出肺结节数多于PET/CT(89 vs 75,p < 0.001)。
  • CT敏感度90%高于PET/CT的76%,但特异度50%低于PET/CT的75%。
  • PET/CT在4例患者中检出更多肺结节、6例中检出更多肺外病变。

核心结论

  • 尽管CT对肺转移结直肠癌的检出能力更强,18F-FDG PET/CT可能有助于检出CT未发现的更多肺及肺外病变。

研究设计与样本

  • 前瞻性研究,对57例因结直肠癌肝转移手术后随访中CT发现肺转移并接受肺转移灶切除的患者行18F-FDG PET/CT,以组织学 findings 为对照,共切除101个肺结节。

诊断标准与关键数值

  • CT检出89个结节 vs PET/CT检出75个结节(p < 0.001)。
  • CT敏感度90% vs PET/CT敏感度76%。
  • CT特异度50% vs PET/CT特异度75%。
  • 阳性预测值与阴性预测值在两种检查间无差异。

临床应用与阅片要点

  • 在结直肠癌肝转移术后随访中,CT发现肺转移时,18F-FDG PET/CT可能有助于发现CT未检出的更多肺结节。
  • 18F-FDG PET/CT可能有助于发现CT未检出的肺外病变(纵隔淋巴结、腹膜后淋巴结、肝转移)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVE: There is currently no conclusive scientific evidence available regarding the role of the 18F-FDG PET/CT for detecting pulmonary metastases from colorectal cancer (PMCRC) in patients operated on for colorectal liver metastases (CRLM). In the follow up of patients who underwent surgery for CRLM, we compare CT-scan and 18F-FDG PET/CT in patients with PMCRC.

METHODS: We designed the study prospectively performing an 18F-FDG PET/CT on all patients operated on for CRLM where the CT-scan detected PMCRC during the follow up. We included patients who were operated on for PMCRC because the histological findings were taken as a control rather than biopsies.

RESULTS: Of the 101 pulmonary nodules removed from 57 patients, the CT-scan identified a greater number (89 nodules) than the 18F-FDG PET/CT (75 nodules) (p < 0.001). Sensitivity was greater with the CT-scan (90 vs 76%, respectively) with a lower specificity (50 vs 75%, respectively) than with the 18F-FDG PET/CT. There were no differences between positive-predictive value and negative-predictive value. The 18F-FDG PET/CT detected more pulmonary nodules in four patients (one PMCRC in each of these patients) and more extrapulmonary disease in six patients (four mediastinal lymph nodes, one retroperitoneal lymph node and one liver metastases) that the CT-scan had not detected.

CONCLUSION: Although CT-scans have a greater capacity to detect PMCRC, the 18F-FDG PET/CT could be useful in the detection of more pulmonary and extrapulmonary disease not identified by the CT-scan. Advances in knowledge: We tried to clarify the utility of 18F-FDG PET/CT in the management of this subpopulation of patients.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Lopez-Lopez V, Robles R, Brusadin R, et al. Role of 18F-FDG PET/CT vs CT-scan in patients with pulmonary metastases previously operated on for colorectal liver metastases. Br J Radiol. 2017. PMID: 29034693. doi:10.1259/bjr.20170216

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。